Document Detail


Enalapril versus atenolol in the treatment of hypertensive smokers.
MedLine Citation:
PMID:  8436148     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A randomised crossover study has been done to compare the antihypertensive efficacy of enalapril and atenolol in 45 smoking, hypertensive men. Treatment was started with enalapril 20 mg/d or atenolol 50 mg/d and, if necessary, the doses were doubled after 4 weeks to achieve a sitting diastolic blood pressure < or = 95 mm Hg, after which hydrochlorothiazide was added, if necessary. Both drugs lowered blood pressure significantly. However, enalapril was more efficient in lowering both systolic and diastolic blood pressure; the mean difference was significant after both 4 and 8 weeks in the sitting systolic (11.6 mm Hg and 7.9 mm Hg) and diastolic (3.3 mm Hg and 3.0 mm Hg) pressures and in the erect systolic pressures (8.2 mm Hg and 7.2 mm Hg), and after 8 weeks in the supine systolic pressure, too (8.9 mm Hg). The effect on enalapril was especially marked in moderate (< 20 cigarettes/day) smokers. The need for diuretics was also significantly less in the enalapril group. It appears that angiotensin-converting enzyme inhibitors may be superior to beta-adrenoceptor blockers in the treatment of hypertensive smoking patients.
Authors:
M Kotamäki; V Manninen; K E Laustiola
Related Documents :
24574958 - Orexin, cardio-respiratory function, and hypertension.
2642658 - Treatment of hypertension in the elderly with a new calcium channel blocking drug, nitr...
22019438 - Flavonoid-rich apples and nitrate-rich spinach augment nitric oxide status and improve ...
3415798 - A comparison of compliance techniques on the control of high blood pressure.
23328258 - Factors associated with elevated plateau pressure in patients with acute lung injury re...
9156228 - Relationship between pulmonary artery diameter at computed tomography and pulmonary art...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European journal of clinical pharmacology     Volume:  44     ISSN:  0031-6970     ISO Abbreviation:  Eur. J. Clin. Pharmacol.     Publication Date:  1993  
Date Detail:
Created Date:  1993-03-23     Completed Date:  1993-03-23     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  1256165     Medline TA:  Eur J Clin Pharmacol     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  13-7     Citation Subset:  IM    
Affiliation:
Wihuri Research Institute, Helsinki, Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Atenolol / therapeutic use*
Blood Pressure / drug effects
Enalapril / therapeutic use*
Heart Rate / drug effects
Humans
Hypertension / drug therapy*,  physiopathology
Male
Middle Aged
Single-Blind Method
Smoking / adverse effects*
Chemical
Reg. No./Substance:
29122-68-7/Atenolol; 75847-73-3/Enalapril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The penetration of ciprofloxacin into bronchial mucosa, lung parenchyma, and pleural tissue after in...
Next Document:  Effects of small doses of bisoprolol on blood pressure and lipoprotein concentrations in hypertensiv...